Merck & Co.
213 E Grand Ave, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA
NEWS
There are hundreds, even thousands of biotech and pharmaceutical companies.
As 2017 comes to a close, 40 drugs have been approved so far, with the record being in 2015, when 46 drugs were approved.
The move is in part related to Brexit, the UK’s exit from the European Union.
Researchers are making great headway against cancer, even though it’s currently still the second-leading cause of death in the U.S.
Under the deal, CUE will leverage its CUE Biologics platform to develop biologics engineered to affect specific T-cell subpopulations to treat autoimmune diseases.
CMV is a common and potentially serious viral infection in allogeneic HSCT recipients.
‘Our track record in R&D was not great for a few years...’
Late on Friday, Merck announced that it had pulled its application for Keytruda in combination with pemetrexed and carboplatin as a first-line treatment for metastatic nonsquamous NSCLC from the EMA.
Merck released its third-quarter financial results today, and along with it a hint--just a hint--that there might be some M&A deals in the future.
JOBS
IN THE PRESS